Navigation Links
Breast milk reduces risk of sepsis and intensive care costs in very-low-birth-weight infants
Date:2/6/2013

CHICAGO -- Feeding human breast milk to very-low-birth-weight infants greatly reduces risk for sepsis and significantly lowers associated neonatal intensive care unit (NICU) costs, according to a study by Rush University Medical Center researchers.

The study, published Jan. 31 in the advance online version of the Journal of Perinatology, showed that every 10 milliliters of human milk per kilogram that a very low birth weight infant received during the first 28 days of life decreased the odds of sepsis by almost 20 percent.

A daily dose of 25 to 49.99 milliliters of human milk per kilogram cut NICU costs by more than $20,000, while 50 milliliters per kilogram per day lowered NICU costs by nearly $32,000.

The research, which was led by Dr. Aloka L. Patel, is the first report of an economic impact of an average daily dose of human milk for days 1 to 28 of life on risk of infection and related hospital care costs. Dr. Patel is an associate professor in pediatrics at Rush University Medical Center. She specializes in neonatal and perinatal medicine.

Of 175 very-low-birth-weight infants, , 23 (13 percent) developed sepsis from gram-positive bacteria such as staphylococci, Streptococcus and Enterococcus species, and gram-negative bacteria such as Escherichia coli (E. coli), as well as species of Klebsiella, Enterobacter, Pseudomonas and Serratia.

Late-onset sepsis commonly occurs in about 22 percent of very-low-birth-weight babies the United States. In addition to predisposing these infants to other diseases and later neurodevelopmental disabilities, sepsis significantly raises NICU costs due to increased use of ventilation and longer lengths of stay. It also translates into higher societal and educational costs for neurologically affected survivors.

"The substantial NICU hospital cost savings associated with increased dosages of human milk are likely to offset the maternal and institutional costs of p
'/>"/>

Contact: John Pontarelli
jpontare@rush.edu
312-942-5949
Rush University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. University of Minnesota researchers discover enzyme behind breast cancer mutations
2. MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients
3. Early breast cancer diagnosis, survival rates low in rural India
4. Moffitt Cancer Center researchers develop automated breast density test linked to cancer risk
5. The nanomechanical signature of breast cancer
6. Study finds hormones can change the breasts genetic material
7. Time spent watching television is not associated with death among breast cancer survivors
8. Breast Cancer Gene May Be Tied to Early Menopause
9. Male Breast Reduction Surgery; More Common than You May Think
10. Less invasive treatment is associated with improved survival in early stage breast cancer
11. Breast Imaging (Breast MRI) Market is Growing at an Estimated CAGR of 15.37% & to Reach $5 Billion by 2017 - by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 This month, Therapy Changes ... to a Successful, Balanced Career.” The guide is geared ... seeking guidance on creating a successful career. , ... focus, determination, and understanding your strengths and limits,” says ... guide will uncover the elements to creating balance in ...
(Date:7/29/2014)... Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American ... access to essential pain medications for people living with ... the Pain initiative, this new partnership will help improve ... throughout the country. , Swaziland has the highest ... percent of adults ages 15-49 infected. Many of these ...
(Date:7/29/2014)... July 29, 2014 Representatives with BNatrl ... product called BNatrl Silver Solution 12ppm . , ... and spokesperson for BNatrl LLC. “It helps boost your ... from harmful pathogens and microbes.” , BNatrl develops and ... water products, with 10 percent of profits being used ...
(Date:7/29/2014)... TN (PRWEB) July 29, 2014 ... specializing in anesthesia, pain management and critical care, has ... “Ryan came to PhyMed in May 2013 as our ... an essential part of our organization and leadership team,” ... “Technological innovation is a cornerstone of our strategic vision ...
(Date:7/29/2014)... This Latest Guidebook for Conducting Pharma Clinical Trials ... only provided a comprehensive and thorough knowledge of the ... registration but also introduced the practical operation how to ... use the Chinese trial venues to keep drug development ... step. , The audiences of this guidebook are overseas ...
Breaking Medicine News(10 mins):Health News:Therapy Changes Releases New Guide to Building a Successful Career 2Health News:New partnership to improve access to essential pain medications for people living with HIV 2Health News:BNatrl Launches New Silver Solution Product 2Health News:PhyMed Names Dorr to Chief Information Office Post 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4
... Complex Rehab Market , , ... with 35 years of experience, has joined Alliance Seating ... complex rehab companies. O,Neill is an Assistive Technology Supplier ... and is responsible for sales and service of rehabilitation equipment ...
... 16 For the past 40 years, arc Thrift ... developmental,disabilities. This week, The Melvin and Elaine Wolf ... a Purpose" program. "As,one of the larger employers of ... partner with The Melvin and Elaine Wolf Foundation to ...
... a neurodegenerative disorder that causes the weakening of muscles, ... in 1 in 6,000 live births. While trans-splicing ... as a treatment for spinal muscular atrophy in cell-based ... the therapy to the human body. A University of ...
... The Journal of Nuclear Medicine SNM,s flagship publicationwill ... change to the publication allows the generous use of ... of research reports," said Heinrich R. Schelbert, M.D., editor ... . "Most important and critical, it strengthens the communication ...
... Mo. Evolving HIV viral strains and the adverse ... treatments propel scientists to continue exploring alternative HIV ... Missouri researcher has identified broad-spectrum aptamers. Aptamers are ... reproducing. In lab tests, aptamers known as RT5, ...
... autism are,struggling with a host of worries that impact ... their family will lack the life-long supports,needed to address ... released today by Easter Seals and made possible by ... Autism Study results reveal parents raising,children with autism are ...
Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:The Melvin and Elaine Wolf Foundation Donates $10,000 to arc Thrift Stores 2Health News:Journal of Nuclear Medicine premiers new, full-color design 2Health News:Researcher refining synthetic molecules to prevent HIV resistance 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 3Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 4Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 5Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 6
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... , July 28, 2014  Dignity Health St. ... received the Get With The Guidelines®-Stroke Silver-Plus Quality ... outlined by the American Heart Association/American Stroke Association ... the number four cause of death and a ... the United States , according to the ...
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... K-V Pharmaceutical Company ( KVa; KVb) (the "Company") ... HOLX ) that site initiation and patient enrollment has ... in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 ... of preterm birth in women pregnant with a single baby ...
... The Wireless-Life Sciences Alliance (WLSA) , which convenes innovators, globally relevant ... in wireless technologies, today hailed its partner organizations for their collaboration and ... , , ... , , ...
Cached Medicine Technology:K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 2K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 3K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 4K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 5K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 6K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 7K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 8K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 9Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 2Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 3
Rapid assay, results in 1 hours,Assay sensitivity of 1.14 ng/mL...
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
... The DIGIVIEW line of digital x-ray ... radiation imaging device complete with 12 to ... area consists of a photodiode array sensor ... All models are available in low x-ray ...
... X-Ray System from KUBTEC is a dual capability ... three dimensional representation of the specimen under test. ... specimen X-ray images, the micro focus source also ... detail in standard 2D images. The 100 mm ...
Medicine Products: